Insight Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Insight Advisors's LLY Position: Q2 2026 in Review
Insight Advisors reduced its Eli Lilly (LLY) stake by 0.26% in Q2 2026, selling an estimated $4.09K and leaving 1,521 shares worth $1.82M. The position accounts for 0.32% of the portfolio, ranked #44.
Insight Advisors first reported a position in LLY in Q1 2022 and has held it in 18 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Insight Advisors held 1,521 shares of Eli Lilly worth $1.82M as of Q2 2026.
- Insight Advisors sold 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
- Eli Lilly made up 0.32% of Insight Advisors's portfolio in Q2 2026, its #44 holding.
- Insight Advisors first reported a position in Eli Lilly in Q1 2022 and has held it in 18 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Insight Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.